Clinical Research Monitoring in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Research Monitoring in Mexico

Clinical Research Monitoring in Mexico – Human Trials in LATAM

Clinical research monitoring is a critical aspect of ensuring the safety and efficacy of pharmaceuticals and medical treatments. In Mexico, this process plays a vital role in advancing healthcare and contributing to global medical knowledge. With its diverse patient population and increasing participation in clinical trials, Mexico has become an attractive destination for clinical research.

However, this growth has also brought about various challenges that researchers, sponsors, and regulatory bodies must address to ensure the highest standards of clinical research monitoring.

The Growth of Clinical Research in Mexico

Mexico has made significant strides in clinical research over the years. Its healthcare infrastructure, diverse population, and regulatory framework have contributed to the country’s emergence as a preferred location for conducting clinical trials. Here are some key factors driving the growth of clinical research in Mexico:

  1. Diverse Patient Population: Mexico’s population is ethnically and culturally diverse, making it an ideal place for conducting trials that require a broad range of patient demographics.
  2. Access to Untapped Markets: The Mexican healthcare system provides access to millions of potential trial participants who have traditionally been underrepresented in clinical research.
  3. Collaboration with Global Pharma: Many global pharmaceutical companies have established a presence in Mexico, leading to increased collaboration in clinical research.
  4. Cost-Effective Trials: Conducting clinical research in Mexico can be more cost-effective compared to developed countries, making it an attractive option for sponsors.

Clinical Research Monitoring in Mexico: Opportunities

  1. Diverse Patient Recruitment: Mexico’s diverse population enables researchers to recruit a wide range of patients, improving the generalizability of study results.
  2. Efficient Regulatory Processes: The regulatory authorities in Mexico, such as the Federal Commission for Protection against Sanitary Risk (COFEPRIS), have made efforts to streamline approval processes, reducing the time required to initiate clinical trials.
  3. Experienced Clinical Trial Workforce: Mexico has a growing pool of experienced clinical research professionals, including investigators, coordinators, and monitors.
  4. Real-World Data Opportunities: The diversity of patients and healthcare settings in Mexico provides opportunities for collecting valuable real-world data that can complement clinical trial results.
  5. Market Access: Conducting clinical trials in Mexico can facilitate faster market access for pharmaceutical products, benefiting both sponsors and patients.

Clinical Research Monitoring in Mexico

Clinical Research Monitoring in Mexico

Clinical Research Monitoring in Mexico

Challenges in Clinical Research Monitoring in Mexico

While Mexico offers numerous advantages for clinical research, it also presents certain challenges that researchers and sponsors must address:

  1. Regulatory Complexity: Despite improvements, navigating the regulatory landscape in Mexico can still be challenging, especially for foreign sponsors unfamiliar with local requirements.
  2. Language Barriers: While English is commonly used in the pharmaceutical industry, language barriers may still pose challenges, particularly in patient interactions and document translations.
  3. Quality of Clinical Sites: Ensuring the quality and consistency of clinical trial sites across different regions of Mexico can be a challenge.
  4. Patient Retention: Maintaining patient engagement and retention throughout a clinical trial can be difficult, particularly in a diverse patient population with varying healthcare access.
  5. Data Privacy and Security: Ensuring the security and privacy of patient data in compliance with international standards is crucial but may require additional efforts.

Best Practices for Clinical Research Monitoring in Mexico

To overcome these challenges and make the most of the opportunities in Mexico’s clinical research landscape, researchers and sponsors should consider the following best practices:

  1. Local Expertise: Collaborate with experienced local partners who understand the regulatory landscape and cultural nuances of Mexico.
  2. Bilingual Staff: Employ bilingual staff to facilitate communication between sponsors, monitors, investigators, and patients.
  3. Quality Assurance: Implement robust quality assurance processes to ensure consistency in data collection and site management.
  4. Patient Engagement: Develop patient engagement strategies that consider the unique healthcare needs and challenges faced by Mexican patients.
  5. Data Security: Invest in secure data management systems and adhere to international data protection standards.


Mexico’s clinical research landscape offers significant opportunities for sponsors and researchers looking to conduct trials with diverse patient populations and cost-effective operations. However, it is essential to navigate the regulatory complexities, language barriers, and cultural differences to ensure the success of clinical research in Mexico.

By embracing best practices and collaborating with local experts, the pharmaceutical industry can continue to contribute to global medical advancements while improving healthcare access for the Mexican population.

Clinical Research Monitoring in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Research Monitoring in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Research Monitoring in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Research Monitoring in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Research Monitoring in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Research Monitoring in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Research Monitoring in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Research Monitoring in Mexico

The Cohortias Team

Clinical Research Monitoring in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Research Monitoring in Mexico

Network & Partnerships